პერიფერული არტერიული დაავადება

Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34;e1-2.სრული ტექსტი  აბსტრაქტი

Bedenis R, Stewart M, Cleanthis M, et al. Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2014 Oct 31;(10):CD003748.სრული ტექსტი  აბსტრაქტი

Chowdhury MM, McLain AD, Twine CP. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. 2014;(6):CD006767.სრული ტექსტი  აბსტრაქტი

Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(suppl 2):e669S-90S. აბსტრაქტი

Abu Dabrh AM, Steffen MW, Asi N, et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg. 2016 Jan;63(1):244-53.სრული ტექსტი  აბსტრაქტი

Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 Apr;45(4):645-54.სრული ტექსტი  აბსტრაქტი

Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature. Atherosclerosis. 2010 Mar;209(1):10-7. აბსტრაქტი

Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015 Jul 9;373(2):145-53.სრული ტექსტი  აბსტრაქტი

1. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018 Mar 1;39(9):763-816.სრული ტექსტი  აბსტრაქტი

2. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Circulation. 2017 Mar 21;135(12):e686-725.სრული ტექსტი  აბსტრაქტი

3. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 20072007 Jun;45(6):1185-91. აბსტრაქტი

4. He Y, Jiang Y, Wang J, et al. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg. 2006 Aug;44(2):333-8. აბსტრაქტი

5. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ. 2003Mar 15;326(7389):584-8. აბსტრაქტი

6. Norgren L, Hiatt WR, Dormandy JA, et al; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-67.სრული ტექსტი  აბსტრაქტი

7. Vitalis A, Lip GY, Kay M, et al. Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2017 Apr;15(4):327-38. აბსტრაქტი

8. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013 Oct 19;382(9901):1329-40. აბსტრაქტი

9. Watson K, Watson BD, Pater KS. Peripheral arterial disease: a review of disease awareness and management. Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79. აბსტრაქტი

10. Abaraogu UO, Ezenwankwo EF, Dall PM, et al. Living a burdensome and demanding life: A qualitative systematic review of the patients experiences of peripheral arterial disease. PLoS One. 2018 Nov 15;13(11):e0207456.სრული ტექსტი  აბსტრაქტი

11. Rajagopalan S. Approach to and management of intermittent claudication. In: Rajagopalan S, Mukherjee D, Mohler ER, eds. Manual of vascular diseases. Philadelphia, PA: Lippincott, Williams and Wilkins; 2005:70-87.

12. Price JF, Mowbray PI, Lee AJ, et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J. 1999 Mar;20(5):344-53.სრული ტექსტი  აბსტრაქტი

13. Youssef F, Gupta P, Mikhailidis DP, et al. Risk modification in patients with peripheral arterial disease: a retrospective survey. Angiology. 2005 May-Jun;56(3):279-87. აბსტრაქტი

14. Paraskevas KI, Papas TT, Pavlidis P, et al. The importance of conservative measures in peripheral arterial disease: an update. Angiology. 2008 Oct-Nov;59(5):529-33. აბსტრაქტი

15. Ostchega Y, Paulose-Ram R, Dillon CF, et al. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2007 Apr;55(4):583-9. აბსტრაქტი

16. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg. 2004 Dec;40(6):1158-65. აბსტრაქტი

17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53. აბსტრაქტი

18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 Nov 7;352(9139):1558. აბსტრაქტი

19. Andersen CA, Roukis TS. The diabetic foot. Surg Clin North Am. 2007 Oct;87(5):1149-77;x. აბსტრაქტი

20. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015 Apr 24;116(9):1509-26. აბსტრაქტი

21. Murabito JM, D'Agostino RB, Silbershatz H, et al. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997 Jul 1;96(1):44-9. აბსტრაქტი

22. Joosten MM, Pai JK, Bertoia ML, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012 Oct 24;308(16):1660-7. აბსტრაქტი

23. Lane DA, Lip GY. Treatment of hypertension in peripheral arterial disease. Cochrane Database Syst Rev. 2013;(12):CD003075.სრული ტექსტი  აბსტრაქტი

24. Thomas Manapurathe D, Krishna SM, Dewdney B, et al. Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: a meta-analysis of randomised controlled trials. PLoS One. 2017 Jun 2;12(6):e0178713.სრული ტექსტი  აბსტრაქტი

25. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 Jan 20;342(3):145-53.სრული ტექსტი  აბსტრაქტი

26. Armstrong EJ, Chen DC, Singh GD, et al. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med. 2015 Jun;20(3):237-44. აბსტრაქტი

27. Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003 Feb 11;107(5):753-6.სრული ტექსტი  აბსტრაქტი

28. Harris SK, Roos MG, Landry GJ. Statin use in patients with peripheral arterial disease. J Vasc Surg. 2016 Dec;64(6):1881-8. აბსტრაქტი

29. National Cholesterol Education Program Expert Panel. Third report: detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. აბსტრაქტი

30. Aung PP, Maxwell HG, Jepson RG, et al. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007;(4):CD000123.სრული ტექსტი  აბსტრაქტი

31. Stoekenbroek RM, Boekholdt SM, Fayyad R, et al. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease. Heart. 2015 Mar;101(5):356-62. აბსტრაქტი

32. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 Aug 10;110(6):738-43. აბსტრაქტი

33. Andras A, Stansby G, Hansrani M. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts. Cochrane Database Syst Rev. 2013;(7):CD003285.სრული ტექსტი  აბსტრაქტი

34. Lane R, Harwood A, Watson L, et al. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;(12):CD000990.სრული ტექსტი  აბსტრაქტი

35. Małecki R, Zdrojowy K, Adamiec R. Thromboangiitis obliterans in the 21st century - a new face of disease. Atherosclerosis. 2009 Oct;206(2):328-34. აბსტრაქტი

36. Esfahani F, Rooholamini SA, Azadeh B, et al. Arterial fibrodysplasia: a regional cause of peripheral occlusive vascular disease. Angiology. 1989 Feb;40(2):108-13. აბსტრაქტი

37. Department of Health, UK. Putting prevention first: vascular checks: risk assessment and management. Impact assessment. Apr 2008 [internet publication].სრული ტექსტი

38. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004 Jul 28;292(4):453-61.სრული ტექსტი  აბსტრაქტი

39. National Institute for Health and Care Excellence. Peripheral arterial disease: diagnosis and management. February 2018 [internet publication].სრული ტექსტი

40. Paraskevas KI, Kotsikoris I, Koupidis SA, et al. Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010 Aug;61(6):521-3. აბსტრაქტი

41. Depalma RG. Impotence in vascular disease: relationship to vascular surgery. Br J Surg. 1982 Jun;69(suppl):S14-S16. აბსტრაქტი

42. Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34;e1-2.სრული ტექსტი  აბსტრაქტი

43. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-296. აბსტრაქტი

44. TASC Steering Committee; Jaff MR, White CJ, Hiatt WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). Vasc Med. 2015 Oct;20(5):465-78. აბსტრაქტი

45. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-248.სრული ტექსტი  აბსტრაქტი

46. Razavi MK, Lee DS, Hofmann LV. Catheter-directed thrombolytic therapy for limb ischemia: current status and controversies. J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):13-23. აბსტრაქტი

47. Guidon M, McGee H. Exercise-based interventions and health-related quality of life in intermittent claudication: a 20-year (1989-2008) review. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):140-54. აბსტრაქტი

48. Mays RJ, Hiatt WR, Casserly IP, et al. Community-based walking exercise for peripheral artery disease: an exploratory pilot study. Vasc Med. 2015 Aug;20(4):339-47. აბსტრაქტი

49. Mangiafico RA, Fiore CE. Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies. Curr Vasc Pharmacol. 2009 Jul;7(3):394-413. აბსტრაქტი

50. National Institute for Health and Care Excellence. Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. May 2011 [internet publication].სრული ტექსტი

51. Pande RL, Hiatt WR, Zhang P, et al. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010 Jun;15(3):181-8.სრული ტექსტი  აბსტრაქტი

52. Bedenis R, Stewart M, Cleanthis M, et al. Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2014 Oct 31;(10):CD003748.სრული ტექსტი  აბსტრაქტი

53. Warner CJ, Greaves SW, Larson RJ, et al. Cilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg. 2014 Jun;59(6):1607-14. აბსტრაქტი

54. Iida O, Yokoi H, Soga Y, et al; STOP-IC investigators. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation. 2013 Jun 11;127(23):2307-15.სრული ტექსტი  აბსტრაქტი

55. De Backer T, Vander Stichele R, Lehert P, et al. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ. 2009 Mar 10;338:b603სრული ტექსტი  აბსტრაქტი

56. Stevens JW, Simpson E, Harnan S, et al. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg. 2012;99:1630-1638. აბსტრაქტი

57. Fakhry F, Fokkenrood HJ, Spronk S, et al. Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database Syst Rev. 2018 Mar 8;(3):CD010512.სრული ტექსტი  აბსტრაქტი

58. Malgor RD, Alahdab F, Elraiyah TA, et al. A systematic review of treatment of intermittent claudication in the lower extremities. Vasc Surg. 2015 Mar Mar;61(3 Suppl):54S-73S. აბსტრაქტი

59. Nicolaï SP, Kruidenier LM, Bendermacher BL, et al. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev. 2013;(6):CD006888.სრული ტექსტი  აბსტრაქტი

60. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev. 2013;(2):CD004001.სრული ტექსტი  აბსტრაქტი

61. Liu Y, Xu Y, Fang F, et al. Therapeutic efficacy of stem cell-based therapy in peripheral arterial disease: a meta-analysis. PLoS One. 2015 Apr 29;10(4):e0125032. აბსტრაქტი

62. Rigato M, Monami M, Fadini GP. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res. 2017 Apr 14;120(8):1326-40. აბსტრაქტი

63. Bachoo P, Thorpe PA, Maxwell H, et al. Endovascular stents for intermittent claudication. Cochrane Database Syst Rev. 2010;(1):CD003228.სრული ტექსტი  აბსტრაქტი

64. Chowdhury MM, McLain AD, Twine CP. Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. 2014;(6):CD006767.სრული ტექსტი  აბსტრაქტი

65. Nguyen BN, Amdur RL, Abugideiri M, et al. Postoperative complications after common femoral endarterectomy. J Vasc Surg. 2015 Jun;61(6):1489-94. აბსტრაქტი

66. Micari A, Nerla R, Vadalà G, et al. 2-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study. JACC Cardiovasc Interv. 2017 Apr 10;10(7):728-34.სრული ტექსტი  აბსტრაქტი

67. Reifsnyder T, Arhuidese IJ, Hicks CW, et al. Contemporary outcomes for open infrainguinal bypass in the endovascular era. Ann Vasc Surg. 2016 Jan;30:52-8. აბსტრაქტი

68. Bedenis R, Lethaby A, Maxwell H, et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev. 2015;(2):CD000535.სრული ტექსტი  აბსტრაქტი

69. Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(suppl 2):e669S-90S. აბსტრაქტი

70. Abu Dabrh AM, Steffen MW, Asi N, et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg. 2016 Jan;63(1):244-53.სრული ტექსტი  აბსტრაქტი

71. Hsu CC, Kwan GN, Singh D, et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Cochrane Database Syst Rev. 2018 Dec 8;(12):CD009195.სრული ტექსტი  აბსტრაქტი

72. Momsen AH, Jensen MB, Norager CB, et al. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg. 2009 Oct;38(4):463-74. აბსტრაქტი

73. Paraskevas KI, Athyros VG, Briana DD, et al. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007 Aug;8(8):942-51. აბსტრაქტი

74. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 Apr;45(4):645-54.სრული ტექსტი  აბსტრაქტი

75. Ahimastos AA, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013 Feb 6;309(5):453-60. აბსტრაქტი

76. Basili S, Raparelli V, Vestri A, et al. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis. Thromb Haemost. 2010 Apr;103(4):766-73. აბსტრაქტი

77. Li L, Geraghty OC, Mehta Z, et al. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017 Jul 29;390(10093):490-9. აბსტრაქტი

78. Kayssi A1, Al-Atassi T, Oreopoulos G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev. 2016;(8):CD011319.სრული ტექსტი  აბსტრაქტი

79. Antoniou GA, Georgiadis GS, Antoniou SA, et al. Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev. 2017;(4):CD002000.სრული ტექსტი  აბსტრაქტი

80. Abu Dabrh AM, Steffen MW, Asi N, et al. Nonrevascularization-based treatments in patients with severe or critical limb ischemia. J Vasc Surg. 201 Nov;62(5):1330-9. აბსტრაქტი

81. Paraskevas KI, Mikhailidis DP. Angiogenesis: a promising treatment option for peripheral arterial disease. Curr Vasc Pharmacol. 2008Apr;6(2):78-80. აბსტრაქტი

82. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature. Atherosclerosis. 2010 Mar;209(1):10-7. აბსტრაქტი

83. Moazzami K, Moazzami B, Roohi A, et al. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia. Cochrane Database Syst Rev. 2014;(12):CD008347.სრული ტექსტი  აბსტრაქტი

84. Teraa M, Sprengers RW, van der Graaf Y, et al. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg. 2013 Dec;258(6):922-9. აბსტრაქტი

85. Food and Drug Administration. FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease. October 2014 [internet publication].

86. Food and Drug Administration. Medtronic IN.PACT Admiral paclitaxel-coated PTA balloon catheter - P140010. December 2014 [internet publication].სრული ტექსტი

87. Rosenfield K, Jaff MR, White CJ, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015 Jul 9;373(2):145-53.სრული ტექსტი  აბსტრაქტი

88. Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015 Feb 3;131(5):495-502.სრული ტექსტი  აბსტრაქტი

89. Kayssi A, Al-Jundi W, Papia G, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Cochrane Database Syst Rev. 2019 Jan 26;(1):CD012510.სრული ტექსტი  აბსტრაქტი

90. Katsanos K, Spiliopoulos S, Kitrou P, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018 Dec 18;7(24):e011245.სრული ტექსტი  აბსტრაქტი

91. Food and Drug Administration. August 7, 2019 UPDATE: treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality. August 2019 [internet publication].სრული ტექსტი

92. Medicines and Healthcare products Regulatory Agency. Recommendations for ongoing use of paclitaxel drug coated balloons (DCBs) and implantable drug eluting stents (DESs) in the treatment of patients with peripheral artery disease (PAD) (MDA/2019/023R). June 2019 [internet publication].სრული ტექსტი

93. Gryka RJ, Buckley LF, Anderson SM. Vorapaxar: the current role and future directions of a novel protease-activated receptor antagonist for risk reduction in atherosclerotic disease. Drugs R D. 2017 Mar;17(1):65-72. აბსტრაქტი

94. Eikelboom JW, Connolly SJ, Bosch J, et al; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017 Oct 5;377(14):1319-30. აბსტრაქტი

95. Anand SS, Bosch J, Eikelboom JW, et al; COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018 Jan 20;391(10117):219-29.სრული ტექსტი  აბსტრაქტი

96. Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk). Circulation. 2018 Jan 23;137(4):338-50.სრული ტექსტი  აბსტრაქტი

97. Davies MG. Criticial limb ischemia: epidemiology. Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):10-4. აბსტრაქტი